At the August 2021 Chromatin Coffee we intertwined a review of news from science and industry with attendees’ commentaries and discussion. We shared thoughts and resources – please scroll down to explore the links referenced that evening.
Highlights
Science news
Florian Wimmers, who spoke at our event on Epigenomics of Immunity in April 2020, has now published his and his team’s findings in Cell. You may also find GenomeWeb coverage and commentary on this work here.
We also highlighted a recent article that reviews the state-of-the-art of machine learning tools in cancer epigenomics.
Industry news
Illumina re-acquired Grail
A definite highlight of the month has been the re-acquisition of Grail by Illumina – we talked about Grail’s mission and what it may mean for the future of the field of early cancer detection.
And if you would like to hear more from Illumina’s CEO himself, you can tune in to the Masters of scale podcast here.
Up and coming proteomics
Finally we talked about two companies that recently gather increasing amounts of attention while embarking on their quest to change the face – and scale – of proteomics.
Seer recently captured GenomeWeb’s headlines with news of their entry into Chinese market.
Nautilus Biotechnology on the other hand has triggered imagination of the tech giant Amazon, securing significant investment.
Update: while Nautilus’s technology is in development, they announced on September 9th that they are targeting release in 2023.
Resources
Below you may find the list of links and resources that the event attendees shared along our discussion that evening:
25th INTERNATIONAL CONFERENCE ON RESEARCH IN COMPUTATIONAL MOLECULAR BIOLOGY.
Machine Learning in Computational Biology.
Illumina’s acquisition of Bluebee.
News of glycosylated RNA – glycoRNA:
Doing PhD in Australia (yes, we talked about that too!).
Bio Bay Area 